SNN vs ZBH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SNN · Smith & Nephew$31.15 ▼ 2.69%
ZBH · Zimmer Biomet Holdings$105.59 ▼ 1.18%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SNN -4.1%
- ZBH +20.3%
Head to head
| Metric | SNN | ZBH |
|---|---|---|
| Price | $31.15 | $105.59 |
| Change today | ▼ 2.69% | ▼ 1.18% |
| Market cap | $13.04B | $19.98B |
| Return, 3 months | +4.8% | +8.3% |
| Return, year to date | -2.5% | +18.4% |
| Return, 1 year | -3.7% | +20.6% |
| P/E (TTM) | 21.2 | 26.7 |
| P/B | 2.5 | 1.6 |
| P/E percentile vs own 5y | 5th | 53rd |
| Dividend yield | 2.51% | 0.91% |
| Revenue growth (YoY, latest qtr) | +6.3% | +4.8% |
| Net profit growth (YoY) | -1.2% | +30.1% |
| Gross margin | 68.2% | 69.9% |
| Operating margin | 13.9% | 16.3% |
| Net margin | 10.1% | 9.5% |
| Return on equity | 11.9% | 6.4% |
| Analyst target vs. price | -0.6% | +8.4% |
| Analyst buy share | 0% | 27% |
| RSI (14) | 61 | 64 |
| 30-day volatility | 33.5% | 46.8% |
| Max drawdown, 1 year | -27.1% | -22.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ZBH is the largest of the group by market value.
- ZBH has returned the most over the past year.
- SNN carries the lowest trailing P/E.
- SNN pays the highest dividend yield.
- SNN is growing revenue fastest.
- SNN keeps the most profit per dollar of sales.
- SNN has been the calmest stock over the last 30 days.